Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- 最新申報
- 2024/11/14
2021 年第 3 季持倉
持倉截至 2021/9/30，2021/11/15 申報。只含多頭部位，變化是跟 2021 年第 2 季比股數。
- 持股檔數
- 55
- 較 2021 年第 2 季 +6
- 總值
- $3.03 億
- 較 2021 年第 2 季 −$1,649 萬 (−5.2%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ASNDAscendis Pharma A/S | SPONSORED ADR | 120,000 | $1,913 萬 | 6.3% | −15,000−11.1% | 減碼 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 700,000 | $1,726 萬 | 5.7% | +250,000+55.6% | 加碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 255,000 | $1,377 萬 | 4.5% | −30,000−10.5% | 減碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 1,500,000 | $1,262 萬 | 4.2% | −100,000−6.3% | 減碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 150,000 | $1,233 萬 | 4.1% | −55,000−26.8% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 790,000 | $1,207 萬 | 4.0% | −60,000−7.1% | 減碼 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 725,000 | $1,177 萬 | 3.9% | 00.0% | 不變 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 575,000 | $1,099 萬 | 3.6% | −300,000−34.3% | 減碼 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 60,000 | $1,062 萬 | 3.5% | +10,000+20.0% | 加碼 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 350,000 | $1,046 萬 | 3.4% | +225,000+180.0% | 加碼 | 歷史 |
| ALLKAllakos Inc. | COM | 85,000 | $899.9 萬 | 3.0% | +85,000 | 新進 | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 400,000 | $882.4 萬 | 2.9% | +400,000 | 新進 | 歷史 |
| KURAKura Oncology, Inc. | COM | 425,000 | $796.0 萬 | 2.6% | −275,000−39.3% | 減碼 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 250,000 | $776.3 萬 | 2.6% | −320,000−56.1% | 減碼 | 歷史 |
| CYPHCypherpunk Technologies Inc. | COM | 1,650,000 | $661.7 萬 | 2.2% | +1,650,000 | 新進 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 200,000 | $659.2 萬 | 2.2% | +200,000 | 新進 | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 700,000 | $614.6 萬 | 2.0% | +100,000+16.7% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 350,000 | $575.8 萬 | 1.9% | 00.0% | 不變 | 歷史 |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 2,000,000 | $548.0 萬 | 1.8% | 00.0% | 不變 | 歷史 |
| AVIRAtea Pharmaceuticals, Inc. | COM | 150,000 | $525.9 萬 | 1.7% | +150,000 | 新進 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 200,000 | $524.2 萬 | 1.7% | +200,000 | 新進 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 275,000 | $495.0 萬 | 1.6% | +25,000+10.0% | 加碼 | 歷史 |
| MLTXMoonLake Immunotherapeutics | COM CL A | 500,000 | $494.3 萬 | 1.6% | 00.0% | 不變 | 歷史 |
| CTICCti Biopharma Corp | COM | 1,600,000 | $472.0 萬 | 1.6% | 00.0% | 不變 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM | 250,000 | $462.3 萬 | 1.5% | +250,000 | 新進 | 歷史 |
| SRRASierra Oncology, Inc. | COM NEW | 200,000 | $438.4 萬 | 1.4% | 00.0% | 不變 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 65,000 | $433.2 萬 | 1.4% | +65,000 | 新進 | 歷史 |
| STSASatsuma Pharmaceuticals, Inc. | COM | 904,225 | $421.4 萬 | 1.4% | 00.0% | 不變 | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 100,000 | $415.9 萬 | 1.4% | −100,000−50.0% | 減碼 | 歷史 |
| GYREGyre Therapeutics, Inc. | COM NEW | 1,000,000 | $411.0 萬 | 1.4% | 00.0% | 不變 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 750,000 | $411.0 萬 | 1.4% | −250,000−25.0% | 減碼 | 歷史 |
| TCRRTCR2 Therapeutics Inc. | COM | 477,323 | $406.2 萬 | 1.3% | +477,323 | 新進 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 160,000 | $405.9 萬 | 1.3% | +15,000+10.3% | 加碼 | 歷史 |
| ALLOAllogene Therapeutics, Inc. | COM | 150,000 | $385.5 萬 | 1.3% | −125,000−45.5% | 減碼 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 170,000 | $366.4 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| NMTR9 Meters Biopharma, Inc. | COM | 2,750,000 | $357.5 萬 | 1.2% | +2,750,000 | 新進 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 150,000 | $315.8 萬 | 1.0% | −93,309−38.3% | 減碼 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 100,000 | $298.7 萬 | 1.0% | +100,000 | 新進 | 歷史 |
| FATEFate Therapeutics Inc | COM | 50,000 | $296.4 萬 | 1.0% | −135,000−73.0% | 減碼 | 歷史 |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 75,000 | $287.5 萬 | 0.9% | −50,000−40.0% | 減碼 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 265,000 | $253.1 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 400,000 | $245.6 萬 | 0.8% | +400,000 | 新進 | – |
| IMUXImmunic, Inc. | COM | 265,000 | $234.5 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| LRMRLarimar Therapeutics, Inc. | COM | 200,000 | $230.6 萬 | 0.8% | +100,000+100.0% | 加碼 | 歷史 |
| MRNAModerna, Inc. | Stock | 5,300 | $204.0 萬 | 0.7% | +1,300+32.5% | 加碼 | 歷史 |
| ALECAlector, Inc. | COM | 80,000 | $182.6 萬 | 0.6% | +80,000 | 新進 | 歷史 |
| MRUSMerus N.V. | COM | 75,000 | $165.0 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| FULCFulcrum Therapeutics, Inc. | COM | 50,000 | $141.1 萬 | 0.5% | +50,000 | 新進 | 歷史 |
| CMRXChimerix Inc | COM | 200,000 | $123.8 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| CABACabaletta Bio, Inc. | COM | 100,000 | $121.6 萬 | 0.4% | +100,000 | 新進 | 歷史 |
| OTICOtonomy, Inc. | COM | 450,000 | $86.4 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| CASICASI Pharmaceuticals, Inc (DE) | COM | 650,000 | $77.4 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| BNTXBioNTech SE | SPONSORED ADS | 2,000 | $54.6 萬 | 0.2% | +2,000 | 新進 | 歷史 |
| TBIOTelesis Bio Inc. | COM | 35,000 | $39.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| PRVBProvention Bio, Inc. | COM | 50,000 | $32.0 萬 | 0.1% | −50,000−50.0% | 減碼 | 歷史 |
選擇權（5 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2021 年第 2 季之後清倉（10 檔）
2021 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 2 季股數 | 2021 年第 2 季市值 | 2021 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| Trillium Therapeutics Inc.89620X506 | COM NEW | 1,250,000 | $1,213 萬 | 3.8% | – |
| BIIBBiogen Inc. | COM | 32,500 | $1,125 萬 | 3.5% | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 180,000 | $698.2 萬 | 2.2% | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 450,000 | $611.1 萬 | 1.9% | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 207,500 | $592.8 萬 | 1.9% | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 75,000 | $516.7 萬 | 1.6% | 歷史 |
| KDMNKadmon Holdings, Inc. | COM | 800,000 | $309.6 萬 | 1.0% | 歷史 |
| CRISCuris Inc | COM NEW | 247,124 | $199.4 萬 | 0.6% | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 75,000 | $192.2 萬 | 0.6% | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 100,000 | $135.7 萬 | 0.4% | 歷史 |